This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Karakousis, P. C.
Right arrow Articles by Dumler, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Karakousis, P. C.
Right arrow Articles by Dumler, J. S.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, June 2006, p. 2283-2287, Vol. 44, No. 6
0095-1137/06/$08.00+0     doi:10.1128/JCM.02365-05
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

CASE REPORT

Chronic Q Fever in the United States

Petros C. Karakousis,1* Michele Trucksis,2 and J. Stephen Dumler3

Departments of Medicine,1 Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland,3 Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts2

Received 11 November 2005/ Returned for modification 11 March 2006/ Accepted 26 March 2006

Infections due to Coxiella burnetii, the causative agent of Q fever, are uncommon in the United States. Cases of chronic Q fever are extremely rare and most often manifest as culture-negative endocarditis in patients with underlying valvular heart disease. We describe a 31-year-old farmer from West Virginia with a history of congenital heart disease and recurrent fevers for 14 months who was diagnosed with Q fever endocarditis based on an extremely high antibody titer against Coxiella burnetii phase I antigen. Despite treatment with doxycycline, he continued to have markedly elevated Coxiella burnetii phase I antibody titers for 10 years after the initial diagnosis. To our knowledge, this case represents the longest follow-up period for a patient with chronic Q fever in the United States. We review all cases of chronic Q fever reported in the United States and discuss important issues pertaining to epidemiology, diagnosis, and management of this disease.

* Corresponding author. Mailing address: Center for Tuberculosis Research, Johns Hopkins University School of Medicine, 1550 Orleans St., Room 106, Baltimore, MD 21231-1002. Phone: (410) 502-8233. Fax: (410) 614-8173. E-mail: petros{at}jhmi.edu.

Journal of Clinical Microbiology, June 2006, p. 2283-2287, Vol. 44, No. 6
0095-1137/06/$08.00+0     doi:10.1128/JCM.02365-05
Copyright © 2006, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Ochoa-Reparaz, J., Sentissi, J., Trunkle, T., Riccardi, C., Pascual, D. W. (2007). Attenuated Coxiella burnetii Phase II Causes a Febrile Response in Gamma Interferon Knockout and Toll-Like Receptor 2 Knockout Mice and Protects against Reinfection. Infect. Immun. 75: 5845-5858 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»